Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) EPS (Basic) (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed EPS (Basic) for 4 consecutive years, with -$9.58 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 77.57% to -$9.58 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$27.98 through Dec 2025, up 62.93% year-over-year, with the annual reading at -$50.83 for FY2025, 47.27% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$9.58 at Spruce Biosciences, up from -$14.58 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.23 in Q4 2023, with the low at -$42.72 in Q4 2024.
  • Average EPS (Basic) over 4 years is -$6.67, with a median of -$0.49 recorded in 2022.
  • The sharpest move saw EPS (Basic) crashed 18473.91% in 2024, then skyrocketed 79.08% in 2025.
  • Over 4 years, EPS (Basic) stood at -$0.47 in 2022, then skyrocketed by 51.06% to -$0.23 in 2023, then plummeted by 18473.91% to -$42.72 in 2024, then soared by 77.57% to -$9.58 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$9.58, -$14.58, and -$3.5 for Q4 2025, Q3 2025, and Q2 2025 respectively.